Sammlung von Newsfeeds
Biotech Distributor BDI Pharma to Continue Accepting Flu Pre Books as New H1N1 ... - PR-USA.net (press release)
Biotech Distributor BDI Pharma to Continue Accepting Flu Pre Books as New H1N1 ...
PR-USA.net (press release)
BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, will continue accepting pre book orders for the 2010 - 2011 flu ...
Kategorien: English
Leo Pharma Taps Intomics for Data Services - GenomeWeb Daily News
Leo Pharma Taps Intomics for Data Services
GenomeWeb Daily News
By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Bioinformatics contract research firm Intomics will provide its services to Leo Pharma for early ...
and more »
Kategorien: English
Should Women Take Hormone Therapy? We Asked An Expert - BuzzFlash (blog)
Should Women Take Hormone Therapy? We Asked An Expert
BuzzFlash (blog)
BuzzFlash contributor Martha Rosenberg spoke with him about the physical and mental costs of horomone therapy for women and the influence of Big Pharma on ...
and more »
Kategorien: English
Vaxart secures $12.5 million in series B financing - Behavioral Health Central (blog)
Vaxart secures $12.5 million in series B financing
Behavioral Health Central (blog)
Mar 05, 2010 (Datamonitor via COMTEX) -- Vaxart, a biotechnology company engaged in developing oral-delivery vaccines, has closed a $12.5 million series B ...
and more »
Kategorien: English
Scientists find new form of prion disease that damages brain arteries - Frontier India - News, Analysis, Opinion
Scientists find new form of prion disease that damages brain arteries
Frontier India - News, Analysis, Opinion
National Institutes of Health (NIH) scientists investigating how prion diseases destroy the brain have observed a new form of the disease in mice that does ...
and more »
Kategorien: English
Pharma News BioSpecifics Technologies Corp. to Host Conference Call to Report ... - Behavioral Health Central (blog)
Pharma News BioSpecifics Technologies Corp. to Host Conference Call to Report ...
Behavioral Health Central (blog)
BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2009 Financial Results on March 10, 2010 LYNBROOK, NY, ...
and more »
Kategorien: English
iBio appoints new chief scientific officer - Behavioral Health Central (blog)
iBio appoints new chief scientific officer
Behavioral Health Central (blog)
... to enable plant-made pharmaceuticals and vaccines will serve us well as we implement our commercial strategy based on the strengths of our technology."
and more »
Kategorien: English
Anthera Pharmaceuticals Completes Initial Public Offering - Behavioral Health Central (blog)
Anthera Pharmaceuticals Completes Initial Public Offering
Behavioral Health Central (blog)
Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with ...
Kategorien: English
Celldex Therapeutics Q4 net loss increases - Behavioral Health Central (blog)
Celldex Therapeutics Q4 net loss increases
Behavioral Health Central (blog)
Mar 05, 2010 (Datamonitor via COMTEX) -- Celldex Therapeutics, a biopharmaceutical company, has reported a net loss of $13.47 million or $0.43 per share, ...
and more »
Kategorien: English
GenVec to Host Fourth Quarter and Year-End 2009 Earnings Call and Webcast - Behavioral Health Central (blog)
GenVec to Host Fourth Quarter and Year-End 2009 Earnings Call and Webcast
Behavioral Health Central (blog)
GAITHERSBURG, Md., March 5 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC) announced that it will release financial results for the fourth quarter and ...
and more »
Kategorien: English
iBio Inc names Dr Vidadi Yusibov as chief scientific officer - Behavioral Health Central (blog)
iBio Inc names Dr Vidadi Yusibov as chief scientific officer
Behavioral Health Central (blog)
Biopharmaceutical company iBio Inc (OTCBB:IBPM) reported on Thursday the appointment of Vidadi Yusibov, Ph.D. as chief scientific officer. ...
and more »
Kategorien: English
Allon Reports 2009 Audited Operating Results and Updates 2010 Plans - Behavioral Health Central (blog)
Allon Reports 2009 Audited Operating Results and Updates 2010 Plans
Behavioral Health Central (blog)
VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 5, 2010) - Allon Therapeutics Inc. (TSX:NPC) today announced its audited operating results for 2009 and ...
and more »
Kategorien: English
Depomed Reports Fourth Quarter and Year-End 2009 Financial Results - Behavioral Health Central (blog)
Depomed Reports Fourth Quarter and Year-End 2009 Financial Results
Behavioral Health Central (blog)
Depomed, Inc. is a specialty pharmaceutical company with one product candidate through Phase 3 clinical development, another in Phase 3 clinical development ...
and more »
Kategorien: English
Inspire Pharmaceuticals Q4 net loss decreases - Behavioral Health Central (blog)
Inspire Pharmaceuticals Q4 net loss decreases
Behavioral Health Central (blog)
Mar 05, 2010 (Datamonitor via COMTEX) -- Inspire Pharmaceuticals, a biopharmaceutical company, has reported a net loss of $2.56 million or $0.03 per share, ...
and more »
Kategorien: English
Merck Statement on Vioxx® Judgment in Australia - Behavioral Health Central (blog)
Merck Statement on Vioxx® Judgment in Australia
Behavioral Health Central (blog)
... due to, among other things, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry; ...
and more »
Kategorien: English
iBio names Vidadi Yusibov CSO - Behavioral Health Central (blog)
iBio names Vidadi Yusibov CSO
Behavioral Health Central (blog)
... and his extensive experience in the development of technology to enable plant-made pharmaceuticals and vaccines will serve iBio well as the company ...
and more »
Kategorien: English
Micromet Q4 net loss widens - Behavioral Health Central (blog)
Micromet Q4 net loss widens
Behavioral Health Central (blog)
Mar 05, 2010 (Datamonitor via COMTEX) -- Micromet, a biopharmaceutical company, has reported a net loss of $23.51 million or $0.34 per share, for the fourth ...
Kategorien: English
Penwest Pharmaceuticals posts net income in Q4 - Behavioral Health Central (blog)
Penwest Pharmaceuticals posts net income in Q4
Behavioral Health Central (blog)
Mar 05, 2010 (Datamonitor via COMTEX) -- Penwest Pharmaceuticals, a biopharmaceutical company, has reported a net income of $1.22 million or $0.04 per share ...
and more »
Kategorien: English
SCANCELL HOLDINGS PLC - Open Offer - Behavioral Health Central (blog)
SCANCELL HOLDINGS PLC - Open Offer
Behavioral Health Central (blog)
The Directors believe that a positive outcome would enable the Company to position itself for a trade sale to one of the leading pharmaceutical or ...
and more »
Kategorien: English
Keryx Biopharmaceuticals to Present at the Cowen and Company 30th Annual ... - Behavioral Health Central (blog)
Keryx Biopharmaceuticals to Present at the Cowen and Company 30th Annual ...
Behavioral Health Central (blog)
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment ...
and more »
Kategorien: English
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- nächste Seite ›
- letzte Seite »
